Leukemia, Mast-Cell
Showing 9976 - 10000 of >10,000
Neuromyelitis Optica Spectrum Disorder Trial in Beijing (Orelabrutinib)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Mar 16, 2022
Leukemia, Myeloid, Acute Trial in Pierre-Bénite (Posaconazole)
Recruiting
- Leukemia, Myeloid, Acute
-
Pierre-Bénite, FranceCentre Hospitalier Lyon Sud, Hematology department
Feb 23, 2022
Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai
Recruiting
- Recurrent Head and Neck Squamous Cell Carcinoma
- Metastatic Head and Neck Squamous Cell Carcinoma
- Camrelizumab
- +4 more
-
Shanghai, Chinathe Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Dec 5, 2021
Non-Malignant Hematologic Disorders Trial in New York (Melphalan, Thiotepa, Clofarabine)
Terminated
- Non-Malignant Hematologic Disorders
- Melphalan
- +5 more
-
New York, New YorkMemorial SloanKettering Cancer Center
Mar 1, 2021
Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)
Recruiting
- Non-small Cell Lung Cancer
- Extensive Disease Small Cell Lung Cancer
-
Akashi, Japan
- +147 more
Jun 23, 2021
Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (IL-2, Stereotactic Ablative Body Radiation Therapy)
Completed
- Metastatic Clear Cell Renal Cell Carcinoma
- IL-2
- Stereotactic Ablative Body Radiation Therapy
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Jul 28, 2021
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (Ulevostinag, Pembrolizumab)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Ulevostinag
- Pembrolizumab
-
Los Angeles, California
- +33 more
Oct 4, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Portland (Carfilzomib, Isatuximab, Pomalidomide)
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Carfilzomib
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 14, 2022
Airway Inflammation in BAL Fluid From Children With Asthma
Completed
- Asthma
-
Denver, ColoradoNational Jewish Health
Oct 19, 2020
Non Small Cell Lung Cancer Trial in Beijing (1.11 GBq of 177Lu-AB-3PRGD2)
Recruiting
- Non Small Cell Lung Cancer
- 1.11 GBq of 177Lu-AB-3PRGD2
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 15, 2021
Fibromyalgia, Chronic Fatigue Syndrome, Multiple Sclerosis Trial in Birmingham ([Zr-89]Oxine-labeled leukocytes PET/MRI)
Recruiting
- Fibromyalgia
- +3 more
- [Zr-89]Oxine-labeled leukocytes PET/MRI
-
Birmingham, AlabamaUAB
Dec 16, 2022
Traumatic Brain Injury, Transfusion Trial in Worldwide (Red Blood Cells Transfusion)
Recruiting
- Traumatic Brain Injury
- Transfusion
- Red Blood Cells Transfusion
-
Barretos, Sao Paulo, Brazil
- +32 more
Aug 16, 2022
Malignant Pleural Disease, Mesothelioma, Metastases Trial in United States (iCasp9M28z T cell infusions, cyclophosphamide,
Active, not recruiting
- Malignant Pleural Disease
- +4 more
- iCasp9M28z T cell infusions
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Nov 14, 2022
ACUTE MYELOID LEUKEMIA Trial in New Haven (Glasdegib, Decitabine)
Terminated
- ACUTE MYELOID LEUKEMIA
-
New Haven, ConnecticutYale Cancer Center/Smilow
Sep 18, 2021
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Hodgkin Lymphoma Trial in New York (Decitabine and
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +5 more
- Decitabine and Cedazuridine
- Nivolumab
-
New York, New YorkNY011 Laura and Isaac Perlmutter Cancer Center at NYU Langone
Jul 8, 2022
NSCLC Trial in Worldwide (Alectnib, Cisplatin, Vinorelbine)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Alectnib
- +5 more
-
Chicago, Illinois
- +140 more
Jan 20, 2023
Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in United
Terminated
- Clear Cell Renal Cell Carcinoma
- +4 more
- Ascorbic Acid
- Pazopanib Hydrochloride
-
Peoria, Illinois
- +4 more
Mar 18, 2022
Healthy Subject, Pancreatic Carcinoma Trial in Palo Alto (diagnostic test, other, drug)
Active, not recruiting
- Healthy Subject
- Pancreatic Carcinoma
- Computed Tomography
- +3 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Apr 8, 2022
CART Treatment, B Cell Lymphoma Trial in Tel-Aviv (Eltrombopag)
Recruiting
- CART Treatment
- B Cell Lymphoma
-
Tel-Aviv, IsraelTel-Aviv Sourasky Medicak center / BMT Unit
Apr 14, 2022
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Hematopoetic Myelodysplasia Trial in Indianapolis, Valhalla (Sitagliptin)
Completed
- Acute Myeloid Leukemia
- +4 more
-
Indianapolis, Indiana
- +1 more
Dec 17, 2018
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Berkeley
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +8 more
- Cobalamin
- +8 more
-
Birmingham, Alabama
- +349 more
Oct 18, 2022
Acute Myeloid Leukemia (AML) Trial in Worldwide (Midostaurin, Midostaurin Placebo, Chemotherapy)
Terminated
- Acute Myeloid Leukemia (AML)
- Midostaurin
- +2 more
-
Chicago, Illinois
- +132 more
Jan 24, 2022
